- Home
- SQFT vs DCOY Comparison
SQFT vs DCOY Comparison
Compare SQFT & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQFT | DCOY |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 5.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SQFT | DCOY |
|---|---|---|
| Price | $3.23 | $0.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 403.5K | ★ 6.2M |
| Earning Date | 02-11-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,525,365.00 | N/A |
| Revenue This Year | $23.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.60 | $0.51 |
| 52 Week High | $23.00 | $52.95 |
Technical Indicators
Market Signals| Indicator | SQFT | DCOY |
|---|---|---|
| Relative Strength Index (RSI) | 40.39 | N/A |
| Support Level | $3.11 | N/A |
| Resistance Level | $3.99 | N/A |
| Average True Range (ATR) | 0.34 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 14.29 | 0.00 |
Price Performance
Historical ComparisonAbout SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About DCOY Decoy Therapeutics Inc. Common Stock
Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.